Healthy adults
Conditions
Interventions
Dissolve 1 bag (high content) in drinks and take before breakfast daily.
Dissolve 1 bag (low content) in drinks and take before breakfast daily.
Dissolve 1 bag (placebo) in drinks and take before brea
Sponsors
IMEQRD Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Aged 20 to under 64 at the time of informed consent 2. Japanese men and women 3. Subjects who deficate 2 to 5 times a week 4. Subjects who can input electronic diary with smartphone / PC 5. Subjects who understand the contents of the trial and obtain written consent before the trial based on the person's free will
Exclusion criteria
Exclusion criteria: Subjects who 1. are currently receiving any types of medicines and/or Chinese medical treatment (except for the drugs taken as needed). 2. are on a diet or exercise therapy under the supervision of a doctor. 3. have a current or history of serious illness. 4. are undergoing treatment for digestive disorders and constipation. 5. have had gastrointestinal surgery (appendicitis is acceptable). 6. take antiflatulent or laxatives daily. 7. take lactic acid bacteria drinks, yogurt or supplements containing lactic acid bacteria daily. 8. take foods for specified health use and foods with functional claims daily. 9. have a past and current medical history of drug or food allergy. 10. have participated in other clinical trials within one month before obtaining consent, or those who plan to participate during the trial period. 11. are currently pregnant or breastfeeding or those who want to become pregnant during the study period. 12. consume alcohol excessively (alcohol equivalent 60g or more / day). 13. have smoking habit. 14. have irregular life rhythms (work in shifts, work late at night etc.). 15. are judged by the investigator to be unsuitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defecation survey (frequency of defecations) | — |
Secondary
| Measure | Time frame |
|---|---|
| Defecation survey (defecation volume, fecal properties by Bristol score and abdominal symptoms etc.), intestinal flora (by T-RFLP) | — |
Countries
Japan
Contacts
Public ContactYoshitada Hira
IMEQRD Co., Ltd Planning and Sales Department
Outcome results
None listed